By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Immune System Diseases and Conditions - HIV/AIDS have been published. According to news reporting originating in San Francisco, California, by NewsRx journalists, research stated, “Preexposure prophylaxis is a highly protective HIV prevention strategy, yet nonadherence can significantly reduce its effectiveness. We conducted a mixed methods evaluation of a mobile health intervention (iText) that utilized weekly bidirectional text or e-mail support messages to encourage preexposure prophylaxis (PrEP) adherence among participants in the multi-site iPrEx open-label extension study.”
The news reporters obtained a quote from the research from the University of California, “A convenience sample of PrEP users from the San Francisco and Chicago sites participated in a 12-week pilot study. Fifty-six men who have sex with men were enrolled; a quarter of them were less than 30 years of age, 13% were black/African American, 11% were Latino, and most (88%) completed some college. Two-thirds opted for text message delivery. Of the 667 messages sent, only 1 individual requested support; initial nonresponse was observed in 22% and was higher among e-mail compared to text message recipients. Poststudy, a majority of participants would recommend the intervention to others, especially during PrEP initiation. Moreover, younger participants and men of color were more likely to report that they would use the iText strategy if it were available to them. Several participants commented that while they were aware that the messages were automated, they felt supported and encouraged that ‘someone was always there.” Study staff reported that the intervention is feasible to administer and can be incorporated readily into clinic flow. A pre-post intervention regression discontinuity analysis using clinic-based pill counts showed a 50% reduction in missed doses [95% confidence interval (CI) 16-71; p = 0.008] and 77% (95% CI 33-92; p = 0.007) when comparing pill counts at quarterly visits just before and after iText enrollment.”
According to the news reporters, the research concluded: “A mobile health intervention using weekly bidirectional messaging was highly acceptable and demonstrated promising effects on PrEP adherence warranting further evaluation for efficacy in a randomized controlled trial.”
For more information on this research see: A Mobile Health Strategy to Support Adherence to Antiretroviral Preexposure Prophylaxis. Aids Patient Care and STDS , 2018;32(3):104-111. Aids Patient Care and STDS can be contacted at: Mary Ann Liebert, Inc, 140 Huguenot Street, 3RD Fl, New Rochelle, NY 10801, USA. (Mary Ann Liebert, Inc. - www.liebertpub.com; Aids Patient Care and STDS - http://www.liebertpub.com/overview/aids-patient-care-and-stds/1/)
Our news correspondents report that additional information may be obtained by contacting J.D. Fuchs, University of California, San Francisco, CA 94143, United States. Additional authors for this research include K. Stojanovski, E. Vittinghoff, V.M. McMahan, S.G. Hosek, K.R. Amico, A. Kouyate, H.J. Gilmore, S.P. Buchbinder, R.T. Lester, R.M. Grant and A.Y. Liu.
The direct object identifier (DOI) for that additional information is: https://doi.org/10.1089/apc.2017.0255. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2018, NewsRx LLC
CITATION: (2018-05-05), Studies from University of California Add New Findings in the Area of HIV/AIDS (A Mobile Health Strategy to Support Adherence to Antiretroviral Preexposure Prophylaxis), Obesity, Fitness & Wellness Week, 4205, ISSN: 1532-4664, BUTTER® ID: 015584963
From the newsletter Obesity, Fitness & Wellness Week.
https://www.newsrx.com/Butter/#!Search:a=15584963
This is a NewsRx® article created by NewsRx® and posted by NewsRx®. As proof that we are NewsRx® posting NewsRx® content, we have added a link to this steemit page on our main corporate website. The link is at the bottom left under "site links" at https://www.newsrx.com/NewsRxCorp/.
We have been in business for more than 20 years and our full contact information is available on our main corporate website.
We only upvote our posts after at least one other user has upvoted the article to increase the curation awards of upvoters.
NewsRx® offers 195 weekly newsletters providing comprehensive information on all professional topics, ranging from health, pharma and life science to business, tech, energy, law, and finance. Our newsletters report only the most relevant and authoritative information from qualified sources.